• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    3.41 Down 0.06(1.73%) Dec 19, 4:04PM EST
    |After Hours : 3.41 0.00 (0.00%) Dec 19, 6:29PM EST
    Add to Portfolio
    Prev Close:3.47
    Open:3.43
    Bid:3.13 x 700
    Ask:3.41 x 500
    1y Target Est:17.50
    Beta:2.97
    Next Earnings Date:N/A
    Day's Range:3.35 - 3.47
    52wk Range:2.29 - 9.46
    Volume:91,358
    Avg Vol (3m):468,930
    Market Cap:30.43M
    P/E (ttm):N/A
    EPS (ttm):-0.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CANF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.33
    Quarterly EPS Est (Sep-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback